TAG/WHO Webinar: Implementing the 4-Month HPMZ Regimen: Experience, Tools, and Next Steps – Recording Now Available Online

8 August 2026

On 9 July 2026, Treatment Action Group (TAG) and the World Health Organization (WHO) co-hosted a webinar focused on the four-month HPMZ (isoniazid, rifapentine, moxifloxacin, pyrazinamide) treatment regimen, covering country experiences, implementation tools, and the availability of new fixed-dose combinations.

The recording of the webinar is now available online and can be accessed here.

Also check out TAG’s latest brief on the HPMZ regimen, Overcoming Barriers to Adopting the Four-Month Regimen: A Pathfinding Mission to Improve Access to Newer TB Treatments.

Source: Treatment Action Group